Nixon Peabody Trust’s Vertiv VRT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$12.7M Sell
37,795
-16,877
-31% -$5.35M 0.9% 34
2026
Q1
$13.7M Sell
54,672
-2,609
-5% -$579K 1.09% 25
2025
Q4
$9.28M Sell
57,281
-17,115
-23% -$2.97M 0.7% 42
2025
Q3
$11.2M Buy
74,396
+1,443
+2% +$192K 0.82% 38
2025
Q2
$9.37M Buy
72,953
+2,987
+4% +$290K 0.73% 44
2025
Q1
$5.05M Buy
69,966
+26,173
+60% +$2.79M 0.43% 59
2024
Q4
$4.98M Buy
+43,793
New +$5.2M 0.41% 52

Other funds holding VRT

Nixon Peabody Trust's VRT Position: Q2 2026 in Review

Nixon Peabody Trust reduced its Vertiv (VRT) stake by 31% in Q2 2026, selling an estimated $5.35M and leaving 37,795 shares worth $12.7M. The position accounts for 0.9% of the portfolio, ranked #34.

Nixon Peabody Trust first reported a position in VRT in Q4 2024 and has held it in 7 quarters since. The position peaked at $13.7M in Q1 2026. 692 funds tracked by Wall St. Rank hold VRT as of Q2 2026.

  • Nixon Peabody Trust held 37,795 shares of Vertiv worth $12.7M as of Q2 2026.
  • Nixon Peabody Trust sold 16,877 Vertiv shares in Q2 2026, an estimated $5.35M.
  • Vertiv made up 0.9% of Nixon Peabody Trust's portfolio in Q2 2026, its #34 holding.
  • Nixon Peabody Trust first reported a position in Vertiv in Q4 2024 and has held it in 7 quarters since.
  • Nixon Peabody Trust's Vertiv position peaked at $13.7M in Q1 2026.
  • 692 funds tracked by Wall St. Rank held Vertiv as of Q2 2026.

Based on Nixon Peabody Trust's 13F filing for Q2 2026, filed 27 Jul 2026.